Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T02:41:10.288Z Has data issue: false hasContentIssue false

Targeting oncofetal high mobility group A2 (HMGA2) to increase sensitivity to temozolomide (TMZ) in glioblastoma (GB) cells

Published online by Cambridge University Press:  30 October 2014

Suchitra Natarajan
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada
Thatchawan Thanasupawat
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada
Amy Rommel
Affiliation:
Laboratory of Genetics, Salk Institute, San Diego, USA
Hugo Bergen
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada
Inder Verma
Affiliation:
Laboratory of Genetics, Salk Institute, San Diego, USA
Marc Del Bigio
Affiliation:
Pathology, University of Manitoba, Winnipeg, MB, Canada
Marshall Pitz
Affiliation:
CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada
Brian B. Hasinoff
Affiliation:
Faculty of Pharmacy, University of Manitoba, Winnipeg, MB, Canada
Jerry Krcek
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada Surgery, University of Manitoba, Winnipeg, MB, Canada
Sabine Hombach-Klonisch
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada
Thomas Klonisch
Affiliation:
Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB, Canada Surgery, University of Manitoba, Winnipeg, MB, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Scientific Oral Presentations 13 June 2014
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2014